文献速递类风湿关节炎

赖氨酸特异性去甲基化酶1通过缺氧诱导因子1α和E2F1代谢整合破骨细胞分化与炎症性骨吸收的作用

Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
PubMed 文献 · Arthritis Rheumatol · 2022-04-27

本研究探讨赖氨酸特异性去甲基化酶1(LSD1)是否在炎症性关节炎状态下代谢整合炎症性破骨细胞生成与骨吸收。在人破骨前体细胞中,RANKL以雷帕霉素机制靶点依赖方式诱导LSD1表达,LSD1抑制可抑制破骨细胞分化;LSD1通过稳定HIF-1α蛋白并上调E2F1促进糖酵解。小鼠模型中抑制LSD1减少病理性骨吸收;RA患者中HIF-1α高表达与骨侵蚀增加相关。

要点

  • RA患者滑膜中LSD1表达高于骨关节炎患者滑膜。
  • 抑制LSD1可抑制人破骨前体细胞的破骨细胞分化。
  • 小鼠模型中抑制LSD1减少加速性骨质疏松及关节炎和炎症性骨溶解模型的病理性骨吸收。

核心结论

  • LSD1在能量需求高的炎症环境中代谢性调节破骨细胞生成,这些发现为靶向破骨细胞治疗炎症性关节炎(包括RA患者)提供了潜在新策略。

研究设计与样本

  • 研究使用LSD1特异性抑制剂和小干扰RNA基因沉默抑制人CD14阳性单核细胞来源的破骨前体细胞中LSD1表达,并进行RNA测序分析。
  • 在实验性小鼠关节炎、炎症性骨溶解或骨质疏松模型中分析加速骨丢失和炎症性骨溶解特征。
  • 在RA患者血液样本中分析顺式表达数量性状位点(cis-eQTL)与缺氧诱导因子1α(HIF-1α)表达的关联,并评估HIF-1α等位基因变异与骨侵蚀程度的关联。

主要发现

  • 在人破骨前体细胞中,RANKL以雷帕霉素机制靶点依赖方式诱导LSD1表达。
  • RA患者滑膜中LSD1表达高于骨关节炎患者滑膜。
  • 抑制人破骨前体细胞中LSD1可抑制破骨细胞分化。
  • 转录组分析结果确定了几条LSD1介导的缺氧和细胞周期通路是参与人破骨细胞生成的关键遗传通路。
  • 在常氧环境中被蛋白酶体快速降解的HIF-1α蛋白,在RANKL刺激的破骨前体细胞中被发现表达;RANKL诱导的LSD1稳定HIF-1α蛋白表达,从而促进糖酵解,并伴随转录因子E2F1上调。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hypoxia occurs in tumors, infections, and sites of inflammation, such as in the affected joints of patients with rheumatoid arthritis (RA). It alleviates inflammatory responses and increases bone resorption in inflammatory arthritis by enhancing osteoclastogenesis. The mechanism by which the hypoxia response is linked to osteoclastogenesis and inflammatory bone resorption is unclear. This study was undertaken to evaluate whether the protein lysine-specific demethylase 1 (LSD1) metabolically integrates inflammatory osteoclastogenesis and bone resorption in a state of inflammatory arthritis. METHODS: LSD1-specific inhibitors and gene silencing with small interfering RNAs were used to inhibit the expression of LSD1 in human osteoclast precursor cells derived from CD14-positive monocytes, with subsequent assessment by RNA-sequencing analysis. In experimental mouse models of arthritis, inflammatory osteolysis, or osteoporosis, features of accelerated bone loss and inflammatory osteolysis were analyzed. Furthermore, in blood samples from patients with RA, cis-acting expression quantitative trait loci (cis-eQTL) were analyzed for association with the expression of hypoxia-inducible factor 1α (HIF-1α), and associations between HIF-1α allelic variants and extent of bone erosion were evaluated. RESULTS: In human osteoclast precursor cells, RANKL induced the expression of LSD1 in a mechanistic target of rapamycin-dependent manner. Expression of LSD1 was higher in synovium from RA patients than in synovium from osteoarthritis patients. Inhibition of LSD1 in human osteoclast precursors suppressed osteoclast differentiation. Results of transcriptome analysis identified several LSD1-mediated hypoxia and cell-cycle pathways as key genetic pathways involved in human osteoclastogenesis. Furthermore, HIF-1α protein, which is rapidly degraded by the proteasome in a normoxic environment, was found to be expressed in RANKL-stimulated osteoclast precursor cells. Induction of LSD1 by RANKL stabilized the expression of HIF-1α protein, thereby promoting glycolysis, in conjunction with up-regulation of the transcription factor E2F1. Analyses of cis-eQTL revealed that higher HIF-1α expression was associated with increased bone erosion in patients with RA. Inhibition of LSD1 decreased pathologic bone resorption in mice, both in models of accelerated osteoporosis and models of arthritis and inflammatory osteolysis. CONCLUSION: LSD1 metabolically regulates osteoclastogenesis in an energy-demanding inflammatory environment. These findings provide potential new therapeutic strategies targeting osteoclasts in the management of inflammatory arthritis, including in patients with RA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Doi K, Murata K, Ito S, et al. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1. Arthritis Rheumatol. 2022. PMID: 35077015. doi:10.1002/art.42074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。